PMC Blog Collaborations, Data, and Policies: Insights From the Personalized Medicine & Diagnostics Track at the 2018 BIO International Convention

by David L. Davenport, Manager of Public Policy, Secretary to the Board, Personalized Medicine Coalition Citing decreasing genetic sequencing costs, the development of new targeted therapies, and the ability to bring together genetic and clinical information with new technologies, Harvard ... Continue reading →